Journal profile · Peripheral Vascular Disease
Hypertension
ISSN 0194-911X · eISSN 1524-4563 · Lippincott Williams and Wilkins Ltd. · UNITED STATES · Monthly · Founded 1979
Hypertension: CAS Zone 1 · Medicine (2025 upgraded edition, Top journal); impact factor 9.34; hybrid open access; median 140 days to acceptance (41 articles, last 24 months); community-reported acceptance: about 37.5%; 799 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Hypertension is published by Lippincott Williams and Wilkins Ltd. and is in Zone 1 of Medicine in the CAS Journal Ranking (2025 upgraded edition, Top journal). By OpenAlex counts of its recent articles, its largest topics are Blood Pressure and Hypertension Studies, Hormonal Regulation and Hypertension and Renin-Angiotensin System Studies, together about 34.6% of its articles. Its main subfields are Cardiology and Cardiovascular Medicine. (generated from OpenAlex topic counts and CAS ranking data)
The No.1 journal serving the international hypertension community through a balance of basic science and clinical research to improve patient care.
From the journal's Aims & Scope
Research area (LetPub): Peripheral Vascular Disease
Editor-in-chief Rhian M. TouyzPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Blood Pressure and Hypertension StudiesMedicine13.4%
- Hormonal Regulation and HypertensionMedicine12.6%
- Renin-Angiotensin System StudiesMedicine8.6%
- Nitric Oxide and Endothelin EffectsMedicine6.5%
- Heart Rate Variability and Autonomic ControlMedicine6.4%
- Sodium Intake and HealthNursing5.7%
- Cardiovascular Health and Disease PreventionMedicine5.2%
- Birth, Development, and HealthMedicine5.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Peripheral Vascular Disease | Zone 1 |
Top journal: yesReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Peripheral Vascular Disease | Zone 1 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Peripheral Vascular Disease | Zone 1 |
Top journal: yesReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 9.34LetPub ·
- CiteScore 2026-06
- 14.6LetPub ·
- SJR 2026-06
- 3.3LetPub ·
- SNIP 2026-06
- 2.64LetPub ·
- h-index
- 246LetPub ·
- h-index
- 370OpenAlex ·
- i10-index
- 13,872OpenAlex ·
- 2-year mean citedness
- 3.7OpenAlex ·
- Self-citation rate
- 4.1%LetPub ·
- Share of gold OA articles
- 19.51%LetPub ·
Volume
- Articles per year
- 203LetPub ·
Articles by year OpenAlex count · 25,248 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 238 | 108 | 213 |
| 2025 | 799 | 160 | 1,822 |
| 2024 | 666 | 186 | 4,264 |
| 2023 | 772 | 241 | 7,612 |
| 2022 | 697 | 281 | 9,825 |
| 2021 | 780 | 405 | 17,119 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
140 daysMedian, submission to acceptance · P25–P75 113 days – 201 days
- Acceptance to online
- median 18 days (41 articles)
- Submission to online
- median 163 days
- Sample
- 41 articles with submission and acceptance dates (1,152 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 1 monthLetPub ·
- Average acceptance (community reports)
- 37.5%LetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
No source has fee information yet; check the journal's website.
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Lippincott Williams and Wilkins Ltd.
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Monthly
- Founded
- 1979
- ISSN
- 0194-911X
- Electronic ISSN
- 1524-4563
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Hypertension
What CAS zone is Hypertension in?
In the 2025 upgraded edition of the CAS Journal Ranking, Hypertension is in Zone 1 of Medicine, and in Zone 1 of the minor category Peripheral Vascular Disease; it is a Top journal. In the 2026 Xinrui edition it is in Zone 1 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Hypertension?
The latest impact factor listed by LetPub is 9.34; CiteScore 14.6, h-index 370.
How long does peer review take at Hypertension?
Based on the dates recorded on 41 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 140 days (interquartile range 113–201 days); authors report an average review time of about 1 month; the community-reported acceptance is “about 37.5%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Hypertension?
According to LetPub and DOAJ records, Hypertension is indexed in SCIE and Scopus.
Is Hypertension open access, and what is the APC?
Hypertension is a hybrid journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .